Literature DB >> 32444413

COVID-19 in Italy: passing through bitter waters.

Lorenzo Guglielmetti1,2,3, Sheila Chiesi4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32444413      PMCID: PMC7243393          DOI: 10.1183/13993003.01812-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
To the Editor: The catastrophic impact of the coronavirus disease 2019 (COVID-19) epidemic in Italy has previously been described [1, 2]. In a recent editorial, Nava et al. [3] paid a well-deserved tribute to the almost 200 healthcare workers who succumbed to COVID-19 in the country in less than 3 months since the first case was reported. We would like to contribute with some considerations on the shortcomings of Italy's response to the pandemic. Around the first COVID-19 cluster in northern Italy, between the regions of Lombardy and Emilia-Romagna, the caseload explosion has been abrupt [4]. Resources quickly became insufficient to provide adequate assistance to all patients [5] As the system became progressively overwhelmed, the death toll started to rise. During these weeks, working among the communities paying the highest price to the epidemic, we have witnessed the relentless commitment of healthcare personnel at all levels. It has been at once moving and disheartening to observe them struggling to cope with unbearable workloads in a system that was not prepared to support them. Faced with exhausting shifts and often without adequate personal protective equipment, healthcare workers have been unsurprisingly affected by high rates of infection and death [6]. Indeed, as shown by Nava et al.[3], 65% of the casualties among medical doctors occurred in the two aforementioned regions. Obvious reasons for Italy's inadequate outbreak response are years of public sector neglect, increased private expenditure and healthcare budget cuts by governments of all political affiliations [7]. Other major shortfalls stem, in our opinion, from the extreme regionalisation of healthcare, which has led to fragmentation of the decision-making process, increased inequalities and a lack of national coordination [8]. For instance, COVID-19 testing policies vary widely in Italy: some regions perform mass contact tracing and outreach activities, while others prioritise severely sick patients. The role of general practitioners in outbreak response activities also differs substantially across the country. This heterogeneity, coupled with ambiguous communication, has generated inefficiencies and confusion. Resource allocation during the emergency was similarly impacted, particularly with regard to the management of intensive care unit (ICU) needs. As previously highlighted, Italy only had a modest number of ICU beds [9]. During recent years, this number has been progressively tapered due to budget necessities, despite repeated warning by experts [10]; this meant that the country was completely unprepared for a high burden of patients who required intensive support. Major differences between regions, even those neighbouring one another, in terms of respiratory equipment availability were obvious on everyday news. Nevertheless, inter-regional collaboration was limited. Most patient transfers to relieve overwhelmed ICUs were performed inside the same region, or towards foreign countries. Finally, the lack of standardisation also affected patient management, which was guided by regional, not national, guidelines. Participation in clinical trials and access to investigational drugs were easier for bigger centres and university hospitals, where greater research experience and manpower facilitated their implementation. To quote a famous colleague, Doctor Van Helsing from Bram Stoker's Dracula, we will have to pass through the bitter waters before reaching the sweet. Once there, though, this historic opportunity for reform should be seized: we should strengthen our public healthcare system, reinforce central governance, reduce inequalities across regions and go back to just hospitals rather than “aziende ospedaliere” (hospital companies). Only then will we be ready to react efficiently to the next pandemic threat while adequately protecting our healthcare workers [1]. This one-page PDF can be shared freely online. Shareable PDF ERJ-01812-2020.Shareable
  7 in total

1.  What Other Countries Can Learn From Italy During the COVID-19 Pandemic.

Authors:  Stefania Boccia; Walter Ricciardi; John P A Ioannidis
Journal:  JAMA Intern Med       Date:  2020-07-01       Impact factor: 21.873

2.  Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line.

Authors:  Lisa Rosenbaum
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

3.  The Toughest Triage - Allocating Ventilators in a Pandemic.

Authors:  Robert D Truog; Christine Mitchell; George Q Daley
Journal:  N Engl J Med       Date:  2020-03-23       Impact factor: 91.245

4.  Cassandra's curse and covid-19: why do governments listen to businesses over doctors?

Authors:  Stephen T Green; Lorenzo Cladi
Journal:  BMJ       Date:  2020-05-13

5.  An Italian sacrifice to the COVID-19 epidemic.

Authors:  Stefano Nava; Roberto Tonelli; Enrico M Clini
Journal:  Eur Respir J       Date:  2020-06-11       Impact factor: 16.671

6.  The Italian health system and the COVID-19 challenge.

Authors:  Benedetta Armocida; Beatrice Formenti; Silvia Ussai; Francesca Palestra; Eduardo Missoni
Journal:  Lancet Public Health       Date:  2020-03-25

Review 7.  COVID-19 and Italy: what next?

Authors:  Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Lancet       Date:  2020-03-13       Impact factor: 79.321

  7 in total
  2 in total

1.  Severe COVID-19 pneumonia in Piacenza, Italy - A cohort study of the first pandemic wave.

Authors:  Lorenzo Guglielmetti; Irina Kontsevaya; Maria C Leoni; Patrizia Ferrante; Elisa Fronti; Laura Gerna; Caterina Valdatta; Alessandra Donisi; Alberto Faggi; Franco Paolillo; Giovanna Ratti; Alessandro Ruggieri; Marta Scotti; Daria Sacchini; Gloria Taliani; Mauro Codeluppi
Journal:  J Infect Public Health       Date:  2020-12-09       Impact factor: 3.718

2.  Public health challenges and opportunities after COVID-19.

Authors:  Pier Luigi Sacco; Manlio De Domenico
Journal:  Bull World Health Organ       Date:  2021-04-29       Impact factor: 9.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.